I. Haagen

发表

Clinical experience with CD3 x CD19 bispecific antibodies in patients with B cell malignancies.

B. Bast, R. D. de Weger, M. Clark, 1995, Journal of hematotherapy.

Interaction of human monocyte Fc gamma receptors with rat IgG2b. A new indicator for the Fc gamma RIIa (R-H131) polymorphism.

J. V. D. van de Winkel, M. Clark, I. Haagen, 1995, Journal of immunology.

Analytical validation of the Hevylite assays for M-protein quantification

S. Croockewit, K. Gelderman, J. Jacobs, 2018, Clinical chemistry and laboratory medicine.

Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayers.

H. Verbrugh, J. Verhoef, I. Haagen, 1990, The Journal of infectious diseases.

CD8 T cell activation after intravenous administration of CD3×CD19 bispecific antibody in patients with non-Hodgkin lymphoma

A. Duits, B. Bast, M. Clark, 1995, Cancer Immunology, Immunotherapy.

Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy.

I. Haagen, 1995, Leukemia & lymphoma.

Clinically relevant discrepancies between different rheumatoid factor assays

W. Lems, D. van Schaardenburg, C. Weykamp, 2018, Clinical chemistry and laboratory medicine.

Killing of Autologous B-Lineage Malignancy Using CD3 x CD19 Bispecific Monoclonal Antibody in End Stage Leukemia and Lymphoma

Clark, B. Bast, I. Haagen, 1994 .

Unprimed CD4+ and CD8+ T cells can be rapidly activated by a CD3×CD19 bispecific antibody to proliferate and become cytotoxic

B. Bast, M. Clark, I. Haagen, 1994, Cancer Immunology, Immunotherapy.

Can serum L-lactate, D-lactate, creatine kinase and I-FABP be used as diagnostic markers in critically ill patients suspected for bowel ischemia

J. Wester, P. V. D. van der Voort, R. Bosman, 2014, BMC Anesthesiology.

The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2.

W. de Lau, B. Bast, I. Haagen, 1995, Blood.

Killing of autologous B-lineage malignancy using CD3 x CD19 bispecific monoclonal antibody in end stage leukemia and lymphoma.

W. de Lau, B. Bast, M. Clark, 1994, Blood.

Killing of human leukaemia/lymphoma B cells by activated cytotoxic T lymphocytes in the presence of a bispecific monoclonal antibody (αCD3/αCD19)

B. Bast, I. Haagen, A. Geerars, 1992 .

PU . 1 as an essential activator for the expression of gp 91 phox gene in human peripheral neutrophils , monocytes , and B lymphocytes ( gene expression y chronic granulomatous disease )

D. Roos, Y. Fujii, A. Kumatori, 1998 .

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients.

J. Casanova, T. Ottenhoff, T. Ottenhoff, 1998, Science.

PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytes.

D. Roos, M. Nakamura, Y. Fujii, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Direct sodium measurement prevents underestimation of hyponatremia in critically ill patients

P. H. Voort, I. Haagen, W. V. D. Ancker, 2015, Intensive Care Medicine.

NUMBER: standardized reference intervals in the Netherlands using a ‘big data’ approach

Christa M Cobbaert, Wendy P J den Elzen, Nannette Brouwer, 2018, Clinical chemistry and laboratory medicine.

Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients

J. Jansen, I. Haagen, R. Vicente‐Steijn, 2020, Practical laboratory medicine.

No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myeloma.

B. Klein, R. Bataille, X. Zhang, 1991, Cancer research.